Abstract

Cervical biopsy results serve as a cornerstone in the clinical management of women with cervical abnormalities, guiding treatment decisions based on the severity of dysplasia or presence of carcinoma. This article explores the impact of cervical biopsy results on treatment decisions, emphasizing clinical considerations that influence therapeutic approaches. Key aspects include risk stratification, management options ranging from observation to interventional procedures, and considerations for fertility and long-term health outcomes. Challenges in diagnostic accuracy, psychosocial impact, and future directions in personalized medicine are also discussed, highlighting the evolving landscape of cervical cancer prevention and management.